Last Updated On 5/5/2025 4:46:19 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
Company: Servier pharmaceuticals |
Recipient: You |
Company: ESMO |
Recipient: You |
Company: Astra Zeneca |
Recipient: You |
Company: Novartis |
Recipient: You |
Company: Gilead Sciences |
Recipient: You |
|
Consulting or Advisory Role |
Company: AstraZeneca |
Recipient: You |
Company: Novartis/Ipsen |
Recipient: You |
Company: Servier/Pfizer |
Recipient: You |
Company: Gilead Sciences |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Tesaro |
Recipient: You |
Company: IQvia |
Recipient: You |
Company: AstraZeneca |
Recipient: You |
Company: Exelixis |
Recipient: You |
Company: PPD Global |
Recipient: You |
Company: MSD |
Recipient: You |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
Company: Pfizer |
Recipient: You |
Company: Karyo |
Recipient: You |
Company: Gilead Sciences |
Recipient: You |
Company: Astra Zenec |
Recipient: You |
Company: Servier |
Recipient: You |
Company: AstraZeneca |
Recipient: You |
Company: Integris |
Recipient: You |
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|